Fahad Amin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fahad Amin has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Raghabendra Kumar Mahato
Gandaki Medical College Teaching Hospital and Research Center, Pokhara, Nepal
5 shared publications - Rija Fatima
King Edward Medical University , Lahore
5 shared publications - Ammad Abid
King Edward Medical University, Neela Gumbad, Lahore, Pakistan
4 shared publications - Atif Ishfaq
King Edward Medical University, Neela Gumbad, Lahore, Pakistan
3 shared publications - Fatima Tu Zahra
King Edward Medical University, Neela Gumbad, Lahore, Pakistan
3 shared publications - Huzaifa Nadeem
King Edward Medical University, Lahore, Pakistan
3 shared publications
Latest Publications
- 13 November 2026
- Published by Oxford University Press (OUP) in Rheumatology
Janus Kinase inhibitors in refractory Takayasu arteritis: a systematic review and proportion meta-analysis of efficacy and safety
Objectives: Takayasu arteritis (TAK) is a rare chronic granulomatous vasculitis affecting large arteries, causing recurrent disease despite standard treatment. This systematic review and meta-analysis aimed to evaluate efficacy and safety of Janus kinase inhibitors in patients with refractory Takayasu arteritis. Methods: We searched five major databases from inception through July 16, 2026, for observational cohorts, non-randomized interventional studies, and case series including ≥5 patients. Eligible studies enrolled adults with refractory TAK treated with JAK inhibitors. Data were pooled using random-effects models. Risk of bias was assessed using Cochrane ROBINS-I and Joanna Briggs Institute tools. The protocol was registered in PROSPERO (CRD420261469541). GRADE was used to assess certainty of primary efficacy outcomes. Results: Eleven studies comprising 185 patients were included. The pooled clinical remission rate was 64% (95% CI, 55%–72%; I²=0%), while complete and partial remission rates were 65% (95% CI, 55%–74%) and 8% (95% CI, 4%–17%), respectively. Pooled rates of no response and relapse were 24% and 14%, respectively. Imaging improvement or stabilization was observed in 44% of patients, while glucocorticoid-sparing effects occurred in 56%. Adverse events occurred in 10% of patients, and 7% discontinued treatment because of adverse events. GRADE certainty was very low for all assessed outcomes. Conclusion: JAK inhibitors demonstrate promising clinical efficacy and a potentially manageable safety profile in refractory TAK. However, the available evidence is predominantly observational and therefore subject to confounding and other sources of bias. High-quality prospective and randomized studies are needed to establish their efficacy, comparative effectiveness, and long-term safety.
- 13 November 2026
- Published by Oxford University Press (OUP) in Rheumatology
Janus Kinase inhibitors in refractory Takayasu arteritis: a systematic review and proportion meta-analysis of efficacy and safety
Objectives: Takayasu arteritis (TAK) is a rare chronic granulomatous vasculitis affecting large arteries, causing recurrent disease despite standard treatment. This systematic review and meta-analysis aimed to evaluate efficacy and safety of Janus kinase inhibitors in patients with refractory Takayasu arteritis. Methods: We searched five major databases from inception through July 16, 2026, for observational cohorts, non-randomized interventional studies, and case series including ≥5 patients. Eligible studies enrolled adults with refractory TAK treated with JAK inhibitors. Data were pooled using random-effects models. Risk of bias was assessed using Cochrane ROBINS-I and Joanna Briggs Institute tools. The protocol was registered in PROSPERO (CRD420261469541). GRADE was used to assess certainty of primary efficacy outcomes. Results: Eleven studies comprising 185 patients were included. The pooled clinical remission rate was 64% (95% CI, 55%–72%; I²=0%), while complete and partial remission rates were 65% (95% CI, 55%–74%) and 8% (95% CI, 4%–17%), respectively. Pooled rates of no response and relapse were 24% and 14%, respectively. Imaging improvement or stabilization was observed in 44% of patients, while glucocorticoid-sparing effects occurred in 56%. Adverse events occurred in 10% of patients, and 7% discontinued treatment because of adverse events. GRADE certainty was very low for all assessed outcomes. Conclusion: JAK inhibitors demonstrate promising clinical efficacy and a potentially manageable safety profile in refractory TAK. However, the available evidence is predominantly observational and therefore subject to confounding and other sources of bias. High-quality prospective and randomized studies are needed to establish their efficacy, comparative effectiveness, and long-term safety.
- 6 November 2026
- Published by Springer Nature in Indian Journal of Surgery
Bag Extraction Versus Direct Extraction for Retrieval of the Gallbladder After Laparoscopic Cholecystectomy: A GRADE-Assessed Systematic Review and Updated Meta-analysis of Randomized Controlled Trials with Trial Sequential Analysis
- 6 November 2026
- Published by Springer Nature in Indian Journal of Surgery
Bag Extraction Versus Direct Extraction for Retrieval of the Gallbladder After Laparoscopic Cholecystectomy: A GRADE-Assessed Systematic Review and Updated Meta-analysis of Randomized Controlled Trials with Trial Sequential Analysis
- Open Access
- 15 October 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
Ultrasound-guided versus anatomical landmark-guided femoral venous access in cardiac electrophysiology procedures
- 15 October 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
Open AccessUltrasound-guided versus anatomical landmark-guided femoral venous access in cardiac electrophysiology procedures
- Open Access
- 12 October 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1) , 641
Magnesium sulfate versus dexmedetomidine as adjuvants for peribulbar block: a GRADE-assessed systematic review and meta-analysis
- 12 October 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1) , 641
Open AccessMagnesium sulfate versus dexmedetomidine as adjuvants for peribulbar block: a GRADE-assessed systematic review and meta-analysis
- Open Access
- 3 October 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Real-world effectiveness and safety of neoadjuvant pembrolizumab in early-stage triple-negative breast cancer: a systematic review and meta-analysis
- 3 October 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Open AccessReal-world effectiveness and safety of neoadjuvant pembrolizumab in early-stage triple-negative breast cancer: a systematic review and meta-analysis
- 21 July 2026
- Published by Wolters Kluwer Health in JPO Journal of Prosthetics and Orthotics
- Vol. 38 (4) , 204-205
Evaluation of a Portable Bionic Ankle Prosthesis under Direct Continuous Electromyography Control for Quiet Standing Tasks: A Critique
Was not provided for this article.
- 21 July 2026
- Published by Wolters Kluwer Health in JPO Journal of Prosthetics and Orthotics
- Vol. 38 (4) , 204-205
Evaluation of a Portable Bionic Ankle Prosthesis under Direct Continuous Electromyography Control for Quiet Standing Tasks: A Critique
Was not provided for this article.
- Open Access
- 20 July 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Effect of irradiance and delivery configuration on phototherapy efficacy in preterm infants: a network meta-analysis and meta-regression of randomized trials
- 20 July 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Open AccessEffect of irradiance and delivery configuration on phototherapy efficacy in preterm infants: a network meta-analysis and meta-regression of randomized trials
- 10 July 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (8)
Therapeutic equivalence of intermittent and continuous phototherapy for neonatal jaundice: a systematic review & meta-analysis with regression and trial sequential analysis
Phototherapy is the mainstay treatment for neonatal hyperbilirubinemia, but the optimal delivery strategy remains debated. Intermittent phototherapy (IMPT) has been proposed as an alternative to continuous phototherapy (CPT) that may achieve comparable bilirubin reduction with fewer adverse effects. This systematic review and meta-analysis evaluated the comparative efficacy and safety of IMPT versus CPT in neonates with hyperbilirubinemia. PubMed, Embase, Scopus, Cochrane Library, and ClinicalTrials.gov were searched through June 2026 for randomized controlled trials comparing IMPT and CPT. Outcomes included rate of fall in bilirubin, follow-up bilirubin, phototherapy duration, hospital stay, and mortality. Random-effects meta-analysis pooled mean differences (MD) and risk ratios (RR) with 95% confidence intervals (CI). Subgroup, meta-regression, and Trial Sequential Analysis (TSA) were performed, and certainty of evidence was graded using GRADE. Twenty-six RCTs (3,891 neonates) were included. No significant difference was found between IMPT and CPT for rate of bilirubin fall, follow-up bilirubin, hospital stay, or mortality. IMPT significantly reduced phototherapy duration (MD - 10.40 h, 95% CI - 18.91 to - 1.88). Heterogeneity was substantial across outcomes. TSA indicated conclusive evidence of equivalence for bilirubin-related and hospital stay outcomes, while evidence for the duration reduction had not yet reached the required information size. Certainty of evidence ranged from low to very low. IMPT achieves outcomes comparable to CPT while significantly reducing treatment duration, supporting its use as a time-efficient alternative, though findings warrant cautious interpretation given low certainty of evidence. • IMPT and CPT show comparable bilirubin reduction, but prior comparisons relied on limited trials without assessing whether the evidence base is conclusive. • This review incorporates the latest trials, applies Cochrane-guided meta-regression, subgroup, leave-one-out, and Hartung-Knapp sensitivity analyses, and uses TSA to confirm conclusive equivalence across major outcomes.
- 10 July 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (8)
Therapeutic equivalence of intermittent and continuous phototherapy for neonatal jaundice: a systematic review & meta-analysis with regression and trial sequential analysis
Phototherapy is the mainstay treatment for neonatal hyperbilirubinemia, but the optimal delivery strategy remains debated. Intermittent phototherapy (IMPT) has been proposed as an alternative to continuous phototherapy (CPT) that may achieve comparable bilirubin reduction with fewer adverse effects. This systematic review and meta-analysis evaluated the comparative efficacy and safety of IMPT versus CPT in neonates with hyperbilirubinemia. PubMed, Embase, Scopus, Cochrane Library, and ClinicalTrials.gov were searched through June 2026 for randomized controlled trials comparing IMPT and CPT. Outcomes included rate of fall in bilirubin, follow-up bilirubin, phototherapy duration, hospital stay, and mortality. Random-effects meta-analysis pooled mean differences (MD) and risk ratios (RR) with 95% confidence intervals (CI). Subgroup, meta-regression, and Trial Sequential Analysis (TSA) were performed, and certainty of evidence was graded using GRADE. Twenty-six RCTs (3,891 neonates) were included. No significant difference was found between IMPT and CPT for rate of bilirubin fall, follow-up bilirubin, hospital stay, or mortality. IMPT significantly reduced phototherapy duration (MD - 10.40 h, 95% CI - 18.91 to - 1.88). Heterogeneity was substantial across outcomes. TSA indicated conclusive evidence of equivalence for bilirubin-related and hospital stay outcomes, while evidence for the duration reduction had not yet reached the required information size. Certainty of evidence ranged from low to very low. IMPT achieves outcomes comparable to CPT while significantly reducing treatment duration, supporting its use as a time-efficient alternative, though findings warrant cautious interpretation given low certainty of evidence. • IMPT and CPT show comparable bilirubin reduction, but prior comparisons relied on limited trials without assessing whether the evidence base is conclusive. • This review incorporates the latest trials, applies Cochrane-guided meta-regression, subgroup, leave-one-out, and Hartung-Knapp sensitivity analyses, and uses TSA to confirm conclusive equivalence across major outcomes.
- 4 June 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1)
Interrupted vs. continuous suture urethroplasty in tubularised incised plate hypospadias: an updated systematic review & meta-analysis
The optimal suturing technique for urethral tubularisation during tubularised incised plate (TIP) urethroplasty remains debated. This systematic review and meta-analysis compared perioperative and postoperative outcomes of interrupted versus continuous suturing techniques in paediatric hypospadias repair. A systematic literature search was performed in PubMed, Cochrane Library, Embase, Scopus, and ClinicalTrials.gov from inception to December 2025 in accordance with PRISMA guidelines. Randomised controlled trials and observational studies comparing interrupted and continuous suturing during paediatric TIP urethroplasty were included. Outcomes assessed were urethrocutaneous fistula, surgical site infection, meatal stenosis, urethral stricture, glans dehiscence, overall complications, urinary stream outcomes, operative time, and reoperation rates. Risk of bias was evaluated using the Cochrane Risk of Bias 2.0 tool and the ROBINS-I. A random-effects meta-analysis supplemented by influence diagnostics and Hartung-Knapp adjustment for heterogeneous outcomes, were conducted using R version 4.5.2, with results expressed as odds ratios (ORs) or mean differences (MDs) and corresponding 95% confidence intervals (CIs). Fifteen studies involving 2625 paediatric patients were included, with 800 undergoing interrupted suturing and 1,825 continuous suturing. No statistically significant differences were observed between techniques for urethrocutaneous fistula (OR 0.65, 95% CI 0.38-1.11), surgical site infection (OR 0.61, 95% CI 0.25-1.48), meatal stenosis (OR 0.98, 95% CI 0.54-1.80), urethral stricture (OR 1.08, 95% CI 0.29-3.97), overall complications (OR 0.75, 95% CI 0.48-1.17), or glans dehiscence (OR 0.77, 95% CI 0.36-1.63). Operating time showed no clinically meaningful difference operative time (MD 3.77 min, 95% CI - 3.69 to 11.24, Hartung-Knapp adjusted). Continuous and interrupted suturing techniques during TIP urethroplasty demonstrate comparable complication rates and functional outcomes. These findings suggest that suturing technique may be selected based on surgeon preference and experience; however, large, well-designed multicentre randomised trials are required to further inform clinical practice.
- 4 June 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1)
Interrupted vs. continuous suture urethroplasty in tubularised incised plate hypospadias: an updated systematic review & meta-analysis
The optimal suturing technique for urethral tubularisation during tubularised incised plate (TIP) urethroplasty remains debated. This systematic review and meta-analysis compared perioperative and postoperative outcomes of interrupted versus continuous suturing techniques in paediatric hypospadias repair. A systematic literature search was performed in PubMed, Cochrane Library, Embase, Scopus, and ClinicalTrials.gov from inception to December 2025 in accordance with PRISMA guidelines. Randomised controlled trials and observational studies comparing interrupted and continuous suturing during paediatric TIP urethroplasty were included. Outcomes assessed were urethrocutaneous fistula, surgical site infection, meatal stenosis, urethral stricture, glans dehiscence, overall complications, urinary stream outcomes, operative time, and reoperation rates. Risk of bias was evaluated using the Cochrane Risk of Bias 2.0 tool and the ROBINS-I. A random-effects meta-analysis supplemented by influence diagnostics and Hartung-Knapp adjustment for heterogeneous outcomes, were conducted using R version 4.5.2, with results expressed as odds ratios (ORs) or mean differences (MDs) and corresponding 95% confidence intervals (CIs). Fifteen studies involving 2625 paediatric patients were included, with 800 undergoing interrupted suturing and 1,825 continuous suturing. No statistically significant differences were observed between techniques for urethrocutaneous fistula (OR 0.65, 95% CI 0.38-1.11), surgical site infection (OR 0.61, 95% CI 0.25-1.48), meatal stenosis (OR 0.98, 95% CI 0.54-1.80), urethral stricture (OR 1.08, 95% CI 0.29-3.97), overall complications (OR 0.75, 95% CI 0.48-1.17), or glans dehiscence (OR 0.77, 95% CI 0.36-1.63). Operating time showed no clinically meaningful difference operative time (MD 3.77 min, 95% CI - 3.69 to 11.24, Hartung-Knapp adjusted). Continuous and interrupted suturing techniques during TIP urethroplasty demonstrate comparable complication rates and functional outcomes. These findings suggest that suturing technique may be selected based on surgeon preference and experience; however, large, well-designed multicentre randomised trials are required to further inform clinical practice.